SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-302298
Filing Date
2017-10-03
Accepted
2017-10-03 16:42:56
Documents
3
Period of Report
2017-10-03
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d458818d8k.htm 8-K 28675
2 EX-3.1 d458818dex31.htm EX-3.1 8344
3 EX-3.2 d458818dex32.htm EX-3.2 128116
  Complete submission text file 0001193125-17-302298.txt   166754
Mailing Address 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address 2225 COLORADO AVENUE SANTA MONICA CA 90404 (310) 824-9999
Kite Pharma, Inc. (Filer) CIK: 0001510580 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36508 | Film No.: 171118562
SIC: 2836 Biological Products, (No Diagnostic Substances)